Live News EQUITY FLASH L impact Nov 03, 2026, 10:59 PM UTC Arovella Therapeutics appoints Nicole van der Weerden acting CEO Arovella Therapeutics appointed Dr Nicole van der Weerden as acting CEO, effective today. SquawkNews Desk